Table 1 Baseline characteristics of the study participants according to clinical cutoffs concentrations of serum 25(OH)D
Clinical cutoffs | 25(OH)D | |||
|---|---|---|---|---|
< 20 (ng/mL) | 20–30 (ng/mL) | ≥ 30 (ng/mL) | p value | |
No. of participants | 4070 (48.1%) | 3382 (40.0%) | 1016 (11.9%) | |
GDM, N (%) | 492 (12.09%) | 329 (9.73%) | 98 (9.65%) | |
Age (years), mean (SD) | 29.17 ± 2.82 | 29.10 ± 2.81 | 28.95 ± 2.91 | 0.099 |
BMI (kg/m2), mean (SD) | 21.11 ± 2.87 | 21.08 ± 2.87 | 20.74 ± 2.81 | < 0.001 |
Laboratory results mean (SD) | ||||
25(OH)D (ng/mL) | 15.10 ± 3.17 | 24.27 ± 2.75 | 34.71 ± 4.41 | < 0.001 |
Tg (mmol/L) | 1.33 ± 0.56 | 1.34 ± 0.74 | 1.32 ± 0.57 | 0.79 |
Tch (mmol/L) | 4.46 ± 0.73 | 4.44 ± 0.73 | 4.39 ± 0.70 | 0.012 |
Fasting glucose (mmol/L) | 4.51 ± 0.38 | 4.46 ± 0.35 | 4.49 ± 0.35 | 0.015 |